Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alterity Therapeutics Ltd ADR
(NQ:
ATHE
)
1.105
-0.065 (-5.56%)
Streaming Delayed Price
Updated: 2:37 PM EST, Nov 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alterity Therapeutics Ltd ADR
< Previous
1
2
3
4
5
6
Next >
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
February 06, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week
January 29, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
January 22, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
January 15, 2024
Via
Benzinga
Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
December 21, 2023
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 05, 2023
Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.
Via
Benzinga
Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
December 05, 2023
Shares of GitLab Inc. (NASDAQ: GTLB) rose sharply in pre-market trading after the company posted better-than-expected results for its third quarter and issued a stro
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 05, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 05, 2023
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest trading news for Tuesday morning!
Via
InvestorPlace
Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress
December 04, 2023
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Why Is Alterity Therapeutics (ATHE) Stock Up 150% Today?
December 04, 2023
Although Alterity Therapeutics revealed encouraging data with its PD therapeutic candidate, ATHE stock still faces challenges.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
December 04, 2023
Via
Benzinga
Biotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Data
December 04, 2023
ATHE stock soared after Alterity Therapeutics disclosed promising new clinical trial data for its Parkinson's disease treatment.
Via
Investor's Business Daily
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 04, 2023
Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20...
Via
Benzinga
Nasdaq Down Over 100 Points; Alaska Air To Acquire Hawaiian Airlines
December 04, 2023
U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 100 points on Monday. Following the market opening Monday, the Dow traded down 0.13% to 36,198.88 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Neurodegenerative Disease-Focused Alterity Therapeutics Stock Trading Over 200% Higher Today?
December 04, 2023
Alterity Therapeutics Inc (NASDAQ: ATHE) shares are trading higher after the company announced that ATHE434 new data in a Parkinson's disease primate model were presented at the Future of Parkinson's
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 04, 2023
Via
Benzinga
Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease
December 04, 2023
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
November 27, 2023
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
November 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 23, 2023
Via
Benzinga
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 22, 2023
Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 22, 2023
Via
Benzinga
Dow Surges 150 Points; US Jobless Claims Decline Sharply
November 22, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 150 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.43% to 35,239.40 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 22, 2023
Via
Benzinga
Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket
November 22, 2023
Shares of Guess?, Inc. (NYSE: GES) shares dipped in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 22, 2023
Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest movements happening this morning!
Via
InvestorPlace
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
November 16, 2023
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy
November 08, 2023
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Appendix 4C – Q1 FY24 Quarterly Cash Flow Report
October 30, 2023
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.